Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial

Benjamin E. Peterson, Deepak L. Bhatt*, Ph Gabriel Steg, Jonas Oldgren, Michael Maeng, Uwe Zeymer, Sigrun Halvorsen, Stefan H. Hohnloser, Gregory Y.H. Lip, Takeshi Kimura, Matias Nordaby, Corinna Miede, Eva Kleine, Jurriën M. ten Berg, Christopher P. Cannon, RE-DUAL PCI Steering Committee and Investigators

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

3 Citations (Scopus)
6 Downloads (Pure)
Original languageEnglish
JournalJACC: Cardiovascular Interventions
Volume14
Issue number7
Pages (from-to)768-780
Number of pages13
ISSN1936-8798
DOIs
Publication statusPublished - 12 Apr 2021

Keywords

  • anticoagulation
  • antiplatelet therapy
  • atrial fibrillation
  • percutaneous coronary intervention

Fingerprint

Dive into the research topics of 'Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial'. Together they form a unique fingerprint.

Cite this